WSL
TIL icon

Western Standard LLC’s Instil Bio TIL Stock Holding History

Western Standard LLC’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-89,849
Closed -$769K – 36
2023
Q3 		$769K Hold
89,849
– – 0.69% 23
2023
Q2 		$990K Hold
89,849
– – 0.85% 21
2023
Q1 		$1.19M Buy
+89,849
New +$1.33M 1.2% 18

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Western Standard LLC's TIL Position: Q4 2023 in Review

Western Standard LLC sold out of Instil Bio (TIL) in Q4 2023, closing a stake of 89,849 shares — an estimated $769K sold.

Western Standard LLC first reported a position in TIL in Q1 2023 and held it in 3 quarters. The position peaked at $1.19M in Q1 2023. 30 funds tracked by Wall St. Rank hold TIL as of Q4 2023.

  • Western Standard LLC reported no remaining Instil Bio position as of Q4 2023 after selling out during the quarter.
  • Western Standard LLC sold 89,849 Instil Bio shares in Q4 2023, an estimated $769K.
  • Western Standard LLC first reported a position in Instil Bio in Q1 2023 and held it in 3 quarters.
  • Western Standard LLC's Instil Bio position peaked at $1.19M in Q1 2023.
  • 30 funds tracked by Wall St. Rank held Instil Bio as of Q4 2023.

Based on Western Standard LLC's 13F filing for Q4 2023, filed 14 Feb 2024.